Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
CYSB2101082	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-06-03	Sanofi (Beijing) Pharmaceuticals Co Ltd			view
CYSB2400236	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-09-13	Zhuhai United Laboratories Co Ltd			view
CYSB2300082	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.4)	Supplementary Application	2023-04-13	Shandong New Time Pharmaceutical Co Ltd			view
JTS2200006	OA-Arg-甘精胰岛素		Active ingredient	Biological Products	Disposable Import Drug Application	2022-02-18				view
JYSB2400080	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08				view
JYSB2101113	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-08-26	Sanofi-Aventis Deutschland GmbH			view
JXSS2101025	甘精胰岛素利司那肽注射液2:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-09-30				view
JYSB2400174	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09				view
JYSZ2300013	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	License Renew	2023-02-28				view
CXSB2101014	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-05-21	Gan & Lee Pharmaceuticals			view
CYSB2300211	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-11-22	Sanofi (Beijing) Pharmaceuticals Co Ltd			view
JXSL2101132	甘精胰岛素利司那肽注射液2:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-11-17				view
CYSB2400141	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals			view
JXSL2101131	甘精胰岛素利司那肽注射液1:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-11-17				view
CYSB2101100	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-06-21	Tonghua Dongbao Pharmaceutical Co Ltd			view
JYSB2400079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08				view
CXSS2200079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	New Drug Application	2022-09-17	Hefei Tianmai BIOTECHNOLOGY Development Co Ltd			view
J0301750-TH	甘精胰岛素注射液	insulin glargine	Injection	Chemical Drugs	Other	2003-12-10				view
JYSB2400173	甘精胰岛素利司那肽注射液（Ⅰ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09				view
JYSB1100220	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2011-09-29	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2012-08-16	view